Latest database descriptions

The main objective of the study is to determine the incidence of chondrosarcoma at 5 years in a population presenting with solitary chondroma. The secondary objectives of the study are: - To determine the incidence of chondrosarcoma at 10 years a population presenting with solitary chondroma -To describe solitary chondroma diagnosis and follow-up modalities - To describe indications for biopsy, curettage or resection - To describe the level of pain and overall quality of life for patients with solitary chondroma as well as the impact of biopsy, curettage or resection -To describe the demographic, clinical, radiological, biological, molecular and genetic factors associated with, or predictive of, sarcomatous change. - To describe the demographic, clinical, radiological, biological, molecular and genetic factors predicting change (improvement or deterioration) in the overall quality of life and level of pain in patients with solitary chondroma - To evaluate the iatrogenic risks of biopsy, curettage or resection of solitary chondroma

The objective is to provide a sample household survey on disability and health. It shall therefore help identify people likely to experience health problems and situations of disability or dependence, in order to over-represent in the health disability survey, a survey seeking to obtain a more precise and detailed knowledge of these issues.

General objective: to assess the prognostic value of a characteristic evaluation of gait in persons suffering from hip osteoarthritis for subsequent indications for total hip replacement. Analysis of the adaptation of locomotor activity as a prognostic criterion for future disease progression.

1. Improve our ability to offer early diagnosis and prevention through identification of valid biomarkers/ bio-signatures of three major mental disorders
2. Identify trajectories of patients moving across stages of disorder and behavioural indicators and biomarkers predecting risk and prognosis
3. Estimate utilization of services, healthcare, societal costs and quality of life of patients suffering from these three disorders
4. Allow national and international academic collaborators or industry partners to access cohort or data collected, to accelerate scientific progress.